The Claim
In patients with coronary artery disease, the presence of lipid-rich plaques identified by NIRS (maxLCBI4mm ≥324.7) independently predicts a 58% higher risk of major adverse cardiac events, regardless of LDL-C level.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with coronary artery disease, fatty plaques detected by a specific imaging test (NIRS with maxLCBI4mm ≥324.7) are associated with a 58% higher rate of serious heart events, even when cholesterol levels are accounted for.
See the scientific wording
In patients with coronary artery disease, the presence of lipid-rich plaques identified by NIRS (maxLCBI4mm ≥324.7) independently predicts a 58% higher risk of major adverse cardiac events, regardless of LDL-C level, indicating that plaque phenotype is a strong prognostic marker beyond traditional risk factors.
Fatty deposits in artery walls attract immune cells that create inflammation and weaken the plaque's outer layer. When this layer breaks, blood clots form suddenly, blocking blood flow to the heart and causing heart attacks or other serious events.
What the research says
1 studyThis study found that people with fatty, unstable plaques in their arteries have a much lower risk of heart problems if their cholesterol is lowered very well — but only if they have those dangerous plaques. So, the type of plaque matters more than just cholesterol numbers alone.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.